Targeted Cancer Therapies are medications that inhibit cancer development and proliferation by interfering with specific molecules involved in the growth or expansion of malignant cells, such as DNA or proteins. Targeted cancer therapies differ from normal chemotherapy in various ways. Standard chemotherapy affects both quickly dividing malignant cells and normal cells, whereas targeted cancer medicines target specific molecular targets linked with cancer. Standard chemotherapy medicines are cytotoxic, meaning they kill tumour cells, but tailored therapies are frequently cytostatic, meaning they prevent tumour cell proliferation.
Chemotherapy drugs can have a wide range of effects on the Targeted Cancer Therapies and healthy cells. The impact of chemotherapy drugs on healthy cells can either increase or decrease their efficiency. Some healthy cells can absorb some of the drugs, increasing their effectiveness, while other cells may be irreparably damaged, preventing them from ever producing any useful product. Cancer survivors are particularly vulnerable to the adverse effects of these drugs, because their healthy cells might be vital to the success of their treatment.
Read More@ https://bit.ly/3EbKNDs
